Atherosclerosis, statins and fibrates treatment benefits

The goal of this Thesis is to analyze atherosclerosis and its relationship to Cardiovascular Disease, as well as the measures taken to oppose the development of an atherosclerotic lesion and its following complications. Aspects such as Diagnosis, Pathogenesis and alteration of endothelium, as well a...

Full description

Bibliographic Details
Main Author: Vechtsalis, Sotiris
Other Authors: Nachtigal, Petr
Format: Dissertation
Language:English
Published: 2015
Online Access:http://www.nusl.cz/ntk/nusl-331974
id ndltd-nusl.cz-oai-invenio.nusl.cz-331974
record_format oai_dc
spelling ndltd-nusl.cz-oai-invenio.nusl.cz-3319742017-06-28T04:18:58Z Atherosclerosis, statins and fibrates treatment benefits Vechtsalis, Sotiris Nachtigal, Petr Rathouská, Jana The goal of this Thesis is to analyze atherosclerosis and its relationship to Cardiovascular Disease, as well as the measures taken to oppose the development of an atherosclerotic lesion and its following complications. Aspects such as Diagnosis, Pathogenesis and alteration of endothelium, as well as complications and clinical manifestations associated to them will be stated. Pharmacological agents opposing the development of this disease will be analyzed, with agents opposing dyslipidemia - one of the major risk factors of developing atherosclerosis - being the center of this paper's focus. In the next chapters, new insight on preventing and treating atherosclerosis using statins and fibrates, analysis of individual statins benefits and toxicities as well as possibilities of their combination benefits and risks will be brought to light. 2015 info:eu-repo/semantics/masterThesis http://www.nusl.cz/ntk/nusl-331974 eng info:eu-repo/semantics/restrictedAccess
collection NDLTD
language English
format Dissertation
sources NDLTD
description The goal of this Thesis is to analyze atherosclerosis and its relationship to Cardiovascular Disease, as well as the measures taken to oppose the development of an atherosclerotic lesion and its following complications. Aspects such as Diagnosis, Pathogenesis and alteration of endothelium, as well as complications and clinical manifestations associated to them will be stated. Pharmacological agents opposing the development of this disease will be analyzed, with agents opposing dyslipidemia - one of the major risk factors of developing atherosclerosis - being the center of this paper's focus. In the next chapters, new insight on preventing and treating atherosclerosis using statins and fibrates, analysis of individual statins benefits and toxicities as well as possibilities of their combination benefits and risks will be brought to light.
author2 Nachtigal, Petr
author_facet Nachtigal, Petr
Vechtsalis, Sotiris
author Vechtsalis, Sotiris
spellingShingle Vechtsalis, Sotiris
Atherosclerosis, statins and fibrates treatment benefits
author_sort Vechtsalis, Sotiris
title Atherosclerosis, statins and fibrates treatment benefits
title_short Atherosclerosis, statins and fibrates treatment benefits
title_full Atherosclerosis, statins and fibrates treatment benefits
title_fullStr Atherosclerosis, statins and fibrates treatment benefits
title_full_unstemmed Atherosclerosis, statins and fibrates treatment benefits
title_sort atherosclerosis, statins and fibrates treatment benefits
publishDate 2015
url http://www.nusl.cz/ntk/nusl-331974
work_keys_str_mv AT vechtsalissotiris atherosclerosisstatinsandfibratestreatmentbenefits
_version_ 1718475656523677696